Kura Oncology (KURA) Shares Outstanding (2010 - 2026)

Kura Oncology (KURA) Shares Outstanding (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 6,012.74 Bn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 47.82 Bn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.44 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 400.00 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 62.06 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Kura Oncology 928.19 Mn 928.19 Mn 18.00 Mn 88.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 88.61 Mn
Dec 31, 2025 87.68 Mn
Sep 30, 2025 87.65 Mn
Jun 30, 2025 87.59 Mn
Mar 31, 2025 87.42 Mn
Dec 31, 2024 86.16 Mn
Sep 30, 2024 86.95 Mn
Jun 30, 2024 86.64 Mn
Mar 31, 2024 83.91 Mn
Dec 31, 2023 73.23 Mn
Sep 30, 2023 77.24 Mn
Jun 30, 2023 69.80 Mn
Mar 31, 2023 68.40 Mn
Dec 31, 2022 66.99 Mn
Sep 30, 2022 66.89 Mn
Jun 30, 2022 66.67 Mn
Mar 31, 2022 66.61 Mn
Dec 31, 2021 66.35 Mn
Sep 30, 2021 66.35 Mn
Jun 30, 2021 66.28 Mn